Medicated chewing gum and a process for preparation thereof

• US 5,866,179 A
• Filed: 05/03/1996
• Issued: 02/02/1999
• Est. Priority Date: 05/03/1996
• Status: Expired due to Term

• Current Assignee: Pierre Fabre Medicament (Fondation Pierre Fabre)
• Original Assignee: Avant-Garde Technologies & Products S.A.
• Inventors: Testa, Emilio Stefano
• Primary Examiner(s): Bawa, Raj
• Application Number:
  US08/646,744
• Time in Patent Office: 1,005 Days
• Field of Search: 424/441, 424/195.1, 424/440, 424/464, 424/484, 426/3, 426/531, 514/343, 514/836
• US Class Current: 426/3
• CPC Class Codes: A61K 47/6951 using cyclodextrin cyclodextrins used as simple excipients A61K47/40
• CPC Class Codes: A61K 9/0058 Chewing gums non-medicinal aspects, preparing chewing gum A23G4/00; chewing gum for care of the teeth or oral cavity, e.g. with breath freshener A61Q11/00
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

The present invention relates to a medicated chewing gum comprising a pharmaceutically active agent incorporated therein. The medicated gum is used as a means for administering the active agent to a subject. The invention also relates to a method of preparing the medicated chewing gum. The process involves the formation of a cyclodextrin-active agent inclusion complex, which is dried and mixed with a granulated gum base without adding water or other solvents. The process is carried out under controlled temperature and humidity and the blended components are cold-pressed to produce a final gum product.

Claims

1. A process for the preparation of medicated chewing gum comprising

(a) forming an inclusion complex of one or more active agents within cyclodextrin,

(b) drying the inclusion complexes of step (a),

(c) mixing the dried inclusion complexes with a granulated gum base and and at least one excipient in the absence of added water or organic solvents under a temperature of below 20°

C. and a maximum relative humidity of 50%, and

(d) cold-pressing the mixture of step (c) under a temperature of below 20°

C. and a maximum relative humidity of 50% to produce a tablet of medicated chewing gum.

2. The process of claim 1, wherein said β

-cyclodextrin is a crystalline β

-cyclodextrin with purity greater than 98%.

3. The process of claim 1, wherein the inclusion of the active agent in the cyclodextrin is carried out by suspending the cyclodextrine in distilled water, homogenizing the suspension by stirring, adding the active agent, mixing until inclusion is completed, removing the water mechanically or by heating, and grinding the resultant powder to obtain a dried blend.

4. The process of claim 1, wherein the gum base comprises natural gum, guar gum and glycerine.

5. The process of claim 1, wherein the excipients comprise carbohydrates.

6. The process of claim 5, wherein the excipients comprise at least one of glucose and sucrose.

7. The process of claim 1, wherein the excipients include non-cavity generating compounds.

8. The process of claim 1, wherein the excipients include sweeteners.

9. The process of claim 7, wherein the non-cavity generating compounds include at least one of mannitol, sorbitol and glycine.

10. The process of claim 8, wherein the sweeteners include at least one of aspartame, cyclohexyl sulfamate, saccharin, acesulfame-k, glycyrrhizinate and sterioside.

11. The process of claim 1, wherein the excipients include compression adjuvants.

12. The process of claim 11, wherein the compression adjuvants include at least one of silicon dioxide, magnesium stearate, calcium stearate, behenic acid.

13. The process of claim 1, wherein the active agent comprises 1-ascorbic acid.

14. The process of claim 1, wherein the active agent comprises acetaminophen.

15. The process of claim 1, wherein the active agent comprises ibuprofen.

16. The process of claim 1, wherein the active agent comprises dimenhydrinate.

17. The process of claim 1, wherein the active agent comprises chlorhexidine diacetate.

18. The process of claim 1, wherein the active agent comprises nicotine.

19. The process of claim 1, wherein the active agent comprises ginseng.

20. The process of claim 1, wherein the active agent comprises ginkgo biloba extract.

21. The process of claim 1, wherein the active agent comprises tea extract.

22. The process of claim 1, wherein the active agent comprises chromo poly picolinate.

23. A medicated chewing gum tablet produced in accordance with the process of claim 1.

24. A medicated chewing gum tablet produced in accordance with the process of claim 2.

25. A medicated chewing gum tablet produced in accordance with the process of claim 4.

26. A medicated chewing gum tablet produced in accordance with the process of claim 5.

27. A medicated chewing gum tablet produced in accordance with the process of claim 6.

28. A medicated chewing gum tablet produced in accordance with the process of claim 7.

29. A medicated chewing gum tablet produced in accordance with the process of claim 8.

30. A medicated chewing gum tablet produced in accordance with the process of claim 9.

31. A medicated chewing gum tablet produced in accordance with the process of claim 10.

32. A medicated chewing gum tablet produced in accordance with the process of claim 11.

33. A medicated chewing gum tablet produced in accordance with the process of claim 12.

34. A medicated chewing gum tablet produced in accordance with the process of claim 13.

35. A medicated chewing gum tablet produced in accordance with the process of claim 14.

36. A medicated chewing gum tablet produced in accordance with the process of claim 15.

37. A medicated chewing gum tablet produced in accordance with the process of claim 16.

38. A medicated chewing gum tablet produced in accordance with the process of claim 17.

39. A medicated chewing gum tablet produced in accordance with the process of claim 18.

40. A medicated chewing gum tablet produced in accordance with the process of claim 19.

41. A medicated chewing gum tablet produced in accordance with the process of claim 20.

42. A medicated chewing gum tablet produced in accordance with the process of claim 21.

43. A medicated chewing gum tablet produced in accordance with the process of claim 22.

44. The process of claim 1, wherein said cyclodextrin is β

-cyclodextrin.